CervoMed
CRVO
2 hedge funds and large institutions have $9K invested in CervoMed in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
+$6.73K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$3.37K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Advisor Group
Phoenix,
Arizona
| $4K | +$6.73K | +2 | New |
|
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3K | +$3.37K | +1 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
4
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
CRVO Hedge Fund Activity: Q4 2016 in Review
2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2016, worth a combined $9K.
Buyers outnumbered sellers: 2 funds opened new CRVO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Advisor Group, opening a new position worth an estimated $6.73K.
- 2 institutional investors held CervoMed (CRVO) as of Q4 2016, up from 0 in Q3 2016.
- Funds reported $9K of CervoMed stock for Q4 2016.
- 2 funds opened new CervoMed positions in Q4 2016 and 0 closed out, a net change of +2 holders.
- The largest CervoMed buyer in Q4 2016 was Advisor Group, an estimated $6.73K added.
Based on aggregated 13F filings for Q4 2016.